These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10148699)

  • 1. Enhancing adherence to referral advice given at blood cholesterol screenings: impact on participant follow-up and physician behavior.
    Lefebvre RC; Banspach SW; Gans KM; Carleton RA; Lasater TM
    Health Educ Res; 1991 Dec; 6(4):405-13. PubMed ID: 10148699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S; Koumjian L; Reisman J; Hso L; Wozenski S
    JAMA; 1991 Jul; 266(3):375-81. PubMed ID: 2056647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of physicians' treatments for referral patients from public cholesterol screening.
    Maiman LA; Greenland P; Hildreth NG; Cox C
    Am J Prev Med; 1991; 7(5):273-9. PubMed ID: 1790032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening and referral on follow-up and treatment of high blood cholesterol levels.
    Råstam L; Luepker RV; Pirie PL
    Am J Prev Med; 1988; 4(5):244-8. PubMed ID: 3224000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intervention on compliance to referral and lifestyle recommendations given at cholesterol screening programs.
    Gans KM; Lapane KL; Lasater TM; Carleton RA
    Am J Prev Med; 1994; 10(5):275-82. PubMed ID: 7848670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes, perceptions and practice of alcohol and drug screening, brief intervention and referral to treatment: a case study of New York State primary care physicians and non-physician providers.
    Harris BR; Yu J
    Public Health; 2016 Oct; 139():70-78. PubMed ID: 27311990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community cholesterol screening. Impact of labeling on participant behavior.
    Gordon RL; Klag MJ; Whelton PK
    Arch Intern Med; 1990 Sep; 150(9):1957-60. PubMed ID: 2393327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in cholesterol awareness and action. Results from national physician and public surveys.
    Schucker B; Wittes JT; Santanello NC; Weber SJ; McGoldrick D; Donato K; Levy A; Rifkind BM
    Arch Intern Med; 1991 Apr; 151(4):666-73. PubMed ID: 2012446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community screening for hypercholesterolemia.
    Bell MM; Joseph S
    J Fam Pract; 1990 Oct; 31(4):365-8. PubMed ID: 2212966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parent and physician response to children's cholesterol values of 200 mg/dL or greater: the Child and Adolescent Trial for Cardiovascular Health Experiment.
    Nader PR; Yang M; Luepker RV; Parcel GS; Pirie P; Feldman HA; Stone EJ; Webber LS
    Pediatrics; 1997 May; 99(5):E5. PubMed ID: 9113962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of public cholesterol screening on diet, general well-being, and physician referral.
    Hyman DJ; Flora JA; Reynolds KD; Johannsson MB; Farquhar JW
    Am J Prev Med; 1991; 7(5):268-72. PubMed ID: 1790031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for high blood cholesterol.
    Schucker B; Bradford RH
    Clin Lab Med; 1989 Mar; 9(1):29-36. PubMed ID: 2647374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid-lowering therapy and patient adherence in the MULTI GAP 2013 trial].
    Simonyi G
    Orv Hetil; 2014 Apr; 155(17):669-75. PubMed ID: 24755449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving referral compliance after public cholesterol screening.
    Maiman LA; Hildreth NG; Cox C; Greenland P
    Am J Public Health; 1992 Jun; 82(6):804-9. PubMed ID: 1316721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can systematic general health screening and patient-physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5-year follow-up].
    Engberg M; Christensen B; Karlsmose B; Lous J; Lauritzen T
    Ugeskr Laeger; 2002 Jun; 164(25):3354-60. PubMed ID: 12107951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group.
    Bradford RH; Bachorik PS; Roberts K; Williams OD; Gotto AM
    Am J Cardiol; 1990 Jan; 65(1):6-13. PubMed ID: 2294681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician follow-up of a community cholesterol-screening project.
    Kass D; Hickner J
    Fam Pract Res J; 1991 Jun; 11(2):139-48. PubMed ID: 2058407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol management in general practice.
    White HL; Roberts DH
    Curr Med Res Opin; 1997; 14(1):53-62. PubMed ID: 9524794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of referral completion after a workplace cholesterol screening program.
    Fitzgerald ST; Gibbens S; Agnew J
    Am J Prev Med; 1991; 7(6):335-40. PubMed ID: 1790040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of referral criteria for public screening of blood cholesterol levels.
    Wones RG; Kerman KM; Hissa DC; Meloy N; Stein EA
    Public Health Rep; 1989; 104(5):425-32. PubMed ID: 2508171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.